Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 1526981, 8 pages
https://doi.org/10.1155/2017/1526981
Research Article

A Downmodulated MicroRNA Profiling in Patients with Gastric Cancer

Department of Gastroenterology, Ruikang Hospital, Guangxi Traditional Chinese Medical University, Nanning, Guangxi 530011, China

Correspondence should be addressed to Yuanneng Chen; moc.nuyila@86606nyc

Received 10 December 2016; Revised 24 February 2017; Accepted 9 March 2017; Published 4 May 2017

Academic Editor: Nicola Silvestris

Copyright © 2017 Tao Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Isomoto, S. Shikuwa, N. Yamaguchi et al., “Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study,” Gut, vol. 58, no. 3, pp. 331–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Jinawath, Y. Furukawa, S. Hasegawa et al., “Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray,” Oncogene, vol. 23, no. 40, pp. 6830–6844, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Stock and F. Otto, “Gene deregulation in gastric cancer,” Gene, vol. 360, no. 1, pp. 1–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, “Identification of novel genes coding for small expressed RNAs,” Science, vol. 294, no. 5543, pp. 853–858, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. L. He and G. J. Hannon, “MicroRNAs: small RNAs with a big role in gene regulation,” Nature Reviews. Genetics, vol. 5, no. 7, pp. 522–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Di Leva, M. Garofalo, and C. M. Croce, “MicroRNAs in cancer,” Annual Review of Pathology, vol. 9, no. 1, pp. 287–314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Esquela-Kerscher and F. J. Slack, “Oncomirs - microRNAs with a role in cancer,” Nature Reviews. Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Shrestha, S. D. Hsu, W. Y. Huang et al., “A systematic review of microRNA expression profiling studies in human gastric cancer,” Cancer Medicine, vol. 3, no. 4, pp. 878–888, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Schetter, S. Y. Leung, J. J. Sohn et al., “MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma,” Journal of the American Medical Association, vol. 299, no. 4, pp. 425–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bloomston, W. L. Frankel, F. Petrocca et al., “MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis,” Journal of the American Medical Association, vol. 297, no. 17, pp. 1901–1908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Sacconi, F. Biagioni, V. Canu et al., “miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer,” Cell Death & Disease, vol. 3, no. 11, p. e423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Nadiminty, R. Tummala, W. Lou et al., “MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells,” The Journal of Biological Chemistry, vol. 287, no. 2, pp. 1527–1537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Krutzfeldt, N. Rajewsky, R. Braich et al., “Silencing of microRNAs in vivo with ‘antagomirs’,” Nature, vol. 438, no. 7068, pp. 685–689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Friedlander, S. D. Mackowiak, N. Li, W. Chen, and N. Rajewsky, “miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades,” Nucleic Acids Research, vol. 40, no. 1, pp. 37–52, 2012. View at Google Scholar
  19. C. Vaz, H. M. Ahmad, P. Sharma et al., “Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood,” BMC Genomics, vol. 11, no. 1, p. 288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Chen, D. A. Ridzon, A. J. Broomer et al., “Real-time quantification of microRNAs by stem-loop RT-PCR,” Nucleic Acids Research, vol. 33, no. 20, article e179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Li, S. Xie, M. Liu et al., “The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis,” International Journal of Oncology, vol. 45, no. 1, pp. 197–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Zhu, M. Wang, F. Yang et al., “miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-kappaB p65 activation,” Oncotarget, vol. 7, no. 13, pp. 16567–16580, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zhang, Y. Song, C. Zhang et al., “Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancer,” Theranostics, vol. 5, no. 7, pp. 733–745, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Zhang, Y. Yin, Y. Hu et al., “MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A,” Medical Oncology, vol. 32, no. 1, p. 331, 2015. View at Google Scholar
  25. Z. Liu, A. Sall, and D. Yang, “MicroRNA: an emerging therapeutic target and intervention tool,” International Journal of Molecular Sciences, vol. 9, no. 6, pp. 978–999, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ueda, S. Volinia, H. Okumura et al., “Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis,” The Lancet Oncology, vol. 11, no. 2, pp. 136–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ozen, C. J. Creighton, M. Ozdemir, and M. Ittmann, “Widespread deregulation of microRNA expression in human prostate cancer,” Oncogene, vol. 27, no. 12, pp. 1788–1793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. S. Imam, J. R. Plyler, H. Bansal et al., “Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization,” PLoS One, vol. 7, no. 12, article e52397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Song, A. Fajol, X. Tu, B. Ren, and S. Shi, “miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2,” Oncotarget, vol. 7, no. 43, pp. 70058–70065, 2016. View at Publisher · View at Google Scholar
  30. Y. Yin, B. Zhang, W. Wang et al., “miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A,” Clinical Cancer Research, vol. 20, no. 23, pp. 6187–6199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Zhang, X. Wang, and P. Chen, “MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells,” BMC Cancer, vol. 13, no. 1, p. 290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Li, H. Pan, and R. Li, “The dual regulatory role of miR-204 in cancer,” Tumour Biology, vol. 37, no. 9, pp. 11667–11677, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Liu, J. Long, R. Du, C. Ge, K. Guo, and Y. Xu, “miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer,” Tumour Biology, vol. 37, no. 6, pp. 8327–8335, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Vigorito, S. Kohlhaas, D. Lu, and R. Leyland, “miR-155: an ancient regulator of the immune system,” Immunological Reviews, vol. 253, no. 1, pp. 146–157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Mashima, “Physiological roles of miR-155,” Immunology, vol. 145, no. 3, pp. 323–333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Seddiki, V. Brezar, N. Ruffin, Y. Levy, and S. Swaminathan, “Role of miR-155 in the regulation of lymphocyte immune function and disease,” Immunology, vol. 142, no. 1, pp. 32–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Costinean, S. K. Sandhu, I. M. Pedersen et al., “Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice,” Blood, vol. 114, no. 7, pp. 1374–1382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. I. A. Babar, C. J. Cheng, C. J. Booth et al., “Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 26, pp. E1695–E1704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. P. S. Eis, W. Tam, L. Sun et al., “Accumulation of miR-155 and BIC RNA in human B cell lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3627–3632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Kluiver, S. Poppema, D. de Jong et al., “BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas,” The Journal of Pathology, vol. 207, no. 2, pp. 243–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Metzler, M. Wilda, K. Busch, S. Viehmann, and A. Borkhardt, “High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma,” Genes, Chromosomes & Cancer, vol. 39, no. 2, pp. 167–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Gironella, M. Seux, M. J. Xie et al., “Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16170–16175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Volinia, G. A. Calin, C. G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. F. Czyzyk-Krzeska and X. Zhang, “MiR-155 at the heart of oncogenic pathways,” Oncogene, vol. 33, no. 6, pp. 677–678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. C. H. Kim, H. K. Kim, R. L. Rettig et al., “miRNA signature associated with outcome of gastric cancer patients following chemotherapy,” BMC Medical Genomics, vol. 4, no. 1, p. 79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Li, F. Luo, Q. Li et al., “Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance,” Oncology Reports, vol. 26, no. 6, pp. 1431–1439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Yao, A. L. Suo, Z. F. Li et al., “MicroRNA profiling of human gastric cancer,” Molecular Medicine Reports, vol. 2, no. 6, pp. 963–970, 2009. View at Publisher · View at Google Scholar
  48. Z. Damavandi, S. Torkashvand, M. Vasei, B. M. Soltani, M. Tavallaei, and S. J. Mowla, “Aberrant expression of breast development-related microRNAs, miR-22, miR-132, and miR-212, in breast tumor tissues,” Journal of Breast Cancer, vol. 19, no. 2, pp. 148–155, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Tian, L. Hou, Y. M. Xiong et al., “miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells,” American Journal of Translational Research, vol. 8, no. 3, pp. 1492–1501, 2016. View at Google Scholar
  50. J. You, Y. Li, N. Fang et al., “MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2,” PLoS One, vol. 9, no. 3, article e91827, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. B. Zheng, H. P. Luo, Q. Shi et al., “miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2,” World Journal of Gastroenterology, vol. 20, no. 21, pp. 6515–6522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Kurokawa, T. Tanahashi, T. Iima et al., “Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells,” Journal of Gastroenterology, vol. 47, no. 8, pp. 883–895, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Jia, K. Wang, A. Zhang et al., “miR-19a and miR-19b overexpression in gliomas,” Pathology Oncology Research, vol. 19, no. 4, pp. 847–853, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Fan, S. Yin, Y. Hao et al., “miR-19b promotes tumor growth and metastasis via targeting TP53,” RNA, vol. 20, no. 6, pp. 765–772, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Liu, R. Yang, U. Urrehman et al., “MiR-19b suppresses PTPRG to promote breast tumorigenesis,” Oncotarget, vol. 7, no. 39, pp. 64100–64108, 2016. View at Publisher · View at Google Scholar